





KidneyFamilial Contributions to the Association
Between Low Birth Weight and Risk of CKD
in Adult LifeAnna Gjerde1,2, Rannveig Skrunes1,3, Anna Varberg Reisæter4, Hans-Peter Marti2,3 and
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plantation Medicine, Rikshospitalet, Oslo University Hospital, Oslo, NorwayIntroduction: Previous studies have revealed that individuals with low birth weight (LBW) have higher risk
of chronic kidney disease (CKD) and that LBW and CKD cluster in families. This study investigates how
familial factors affect the association between birth-related risk markers and risk of CKD.
Methods: The Medical Birth Registry (MBR) of Norway has registered all births in Norway since 1967.
Sibling data were available through the Norwegian Population Registry. The Norwegian Patient Registry
has registered diagnostic codes for all admissions and outpatient visits to Norwegian hospitals since 2008.
Data from these registries were linked. Risk of CKD according to whether the individual himself or at least
one of his siblings had LBW was analyzed using logistic regression statistics.
Results: Of 1,847,565 individuals, 3336 had been diagnosed with CKD. Compared with individuals without
LBW and no siblings with LBW, individuals without LBW but who had a sibling with LBW had adjusted
odds ratio (aOR) of 1.33 (1.19–1.49), those with LBW but no siblings with LBW had aOR of 1.74 (1.55–1.95),
and those with LBW and a sibling with LBW had aOR of 1.77 (1.54–2.04) for CKD. Similar results were
found for LBW for gestational age, but preterm birth revealed weaker associations.
Conclusion: Individuals who have a sibling with LBW have an increased risk of CKD later in life, and in-
dividuals who themselves have LBW have an even higher risk. Our findings suggest that there are familial
contributions to the nephron endowment in utero hypothesis.
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everal hypotheses have been proposed during the
past decades suggesting that birth weight is
inversely associated with risk of cardiovascular and
other metabolic diseases in adult life through mecha-
nisms of malnutrition in utero,1 unmeasured socioeco-
nomic confounding,2 and genetic or other
intergenerational factors influencing both birth weight
and adult disease risk.3 Several studies have also
revealed that both maternal and paternal genetic fac-
tors are associated with offspring birth weight.4–6 At
the same time, there is a strong association between
family history of end-stage kidney disease and
increased risk of end-stage kidney disease.7–11 Despite aspondence: Anna Gjerde, Department of Medicine, Haugesund
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International Reports (2021) 6, 2151–2158large number of studies during the past decades, the
environmental versus familial contribution to the
increased familial risk of kidney disease is still unclear.
The nephron endowment in utero hypothesis stated
that as kidneys are developed in utero, risk of kidney
disease in later life could be partially determined at
birth.12 Several studies have supported this, and in-
dividuals with LBW seem to have a 70% to 80%
increased risk of kidney disease in adult life.13,14 To
investigate whether this association was confounded by
familial factors, our research group previously published
a study that investigated whether having a sibling with
LBW was associated with an increased risk of end-stage
kidney disease; the study revealed that only individuals
who themselves had LBW had an increased risk and not
individuals who had a sibling with LBW.15 No studies
have however investigated the possible confounding
role of familial factors in the association between birth-
related risk markers and later CKD in general.2151
CLINICAL RESEARCH A Gjerde et al.: Familial Contributions to Low Birth Weight and CKDThe MBR of Norway has registered data on all births
in Norway since 1967, and sibling data have been
registered in the Norwegian Population Registry. All
patients who had been diagnosed with kidney disease
during admissions or outpatient visits to Norwegian
hospitals during the period 2008 to 2016 had been
registered in the NPR. We linked these registries and
studied how risk of CKD was affected by whether the
individual himself or at least one of his/her siblings had
LBW or small for gestational age (SGA). We hypothe-
sized that family factors might modify effects of
adverse birth-related markers and risk of CKD.
METHODS
The MBR of Norway has registered extensive medical
data on all births in Norway since 1967. Maternal and
paternal national identification numbers have been
registered in the Norwegian Population Registry. The
NPR has registered International Classification of Dis-
eases Tenth Revision (ICD-10) diagnostic codes for all
admissions and outpatient visits to Norwegian hospi-
tals since 2008; in Norway, most nephrologists are
hospital based, and the data are therefore almost com-
plete for specialist care. ICD-10 codes were registered
by the treating physicians. In this study, we obtained
data from the NPR for the period 2008 to 2016. The
Norwegian Populaton Registry had date of death for all
participants who died, until the end of 2016. We linked
these registries using the national identification
number.
All individuals registered in the MBR between 1967
and 2015 who had at least 1 sibling registered in the
MBR during the same period were selected (N ¼
2,016,267). Siblings were defined as individuals with
the same mother and father. Individuals with no sib-
lings and those with more than 7 siblings (N ¼ 3789)
were excluded to enable practical data handling and to
avoid effect modification by very large number of
siblings (with higher risks of at least 1 with LBW by
chance). We also excluded individuals who had at least
1 sibling (including themselves) with multiple births
(N ¼ 69,751), those who died before age 1 year (N ¼
12,606), those who died before 2008 (N ¼ 14,428), and
those who had officially emigrated from Norway (N ¼
66,282). That left 1,849,411 individuals to be included
in the analyses.
Birth-Related Variables
LBW was defined as birth weight less than the 10th
percentile for gender (2970 g for men, 2880 g for
women). From 1967 to 1998, gestational age was based
on the last menstrual period and from 1999 onward on
routine ultrasonographic examination in gestational
weeks 17 to 20. For use in this study, gestational age2152was available for 95.6% of the participants and birth
weight was available for 99.93% of the participants. On
the basis of birth weight, gestational age, and gender, a
z-score of birth weight for gestational age was calcu-
lated. We defined SGA as birth weight less than the
10th percentile for gestational age and gender (the 10%
with the lowest z-score for each gender) (cutoff 1.30
for men and 1.28 for women). Preterm birth was
defined as birth before 37 weeks of gestation. LBW, less
than 2500 g, was also analyzed as an exposure variable.
In this study, pregestational maternal disease was
defined as a diagnosis of maternal diabetes mellitus,
kidney disease, rheumatic disease, or essential hyper-
tension before pregnancy. Maternal marital status was
dichotomized as either single (divorced or not living
with partner) or not single (married or living with
partner). Congenital malformations in the newborns
were recorded as present if any malformation were
observed before discharge from the hospital after birth;
in the statistical analyses, a dichotomous variable was
used.
Outcome Variables
The main outcome was defined as having been diag-
nosed with CKD (ICD-10 code N18) in at least one of the
hospital contacts (admissions or outpatient visits). Both
main and secondary diagnoses were included. The
secondary outcomes were having been diagnosed with
the following different groups of kidney disease: acute
kidney disease (N17), glomerular disease (N00–N09),
hereditary cystic renal disease (Q61), or kidney or
urinary tract malformations (Q60, Q62–Q64).
The data file from NPR included ICD-10 codes for
each hospital contact (admission or outpatient visit)
with a kidney disease diagnosis (N01–N09, N17–N19,
N25–N29, or Q60–Q64). Of the 1,849,411 individuals,
11,553 were registered with at least 1 episode of kidney
disease (maximum 1370 episodes); 4464 had 1 episode,
1603 had 2 episodes, 925 had 3 episodes, 2475 had 4 to
9 episodes, 1146 had 10 to 19 episodes, and 940 had
greater than or equal to 20 episodes. Patients were
diagnosed with different combinations and sequences
of ICD-10 codes, and for this study, we focused on
whether or not a diagnosis or group of diagnoses had
been recorded at least once.
Statistical Analysis
Data were analyzed in a cohort design with birth-
related variables for the included individual and his/
her sibling(s) as exposure variables and CKD and other
kidney diagnoses as outcomes. Characteristics of
different groups were compared using t tests for
continuous variables and Pearson’s chi-square test for
categorical variables. Risks were analyzed usingKidney International Reports (2021) 6, 2151–2158
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N total 1,483,071 181,507 111,387 71,600
Mean number of siblings 1.6  0.8 1.9  1.0a 1.5  0.7a 1.7  0.9a
Mean number of years of follow-up 28.4  12.4 29.0  12.2a 29.2  12.6a 29.2  12.4a
Proportion with preterm birth 1.5% 2.6%a 28.0%a 28.1%a
Proportion with SGA 3.5% 9.4%a 60%a 65%a
Proportion with maternal preeclampsia 2.1% 2.7%a 8.5%a 8.1%a
Proportion with 5-min Apgar score <7 0.7% 0.6% 2.6%a 2.4%a
Proportion with maternal diseaseb 2.2% 2.5%a 2.7%a 3.4%a
Form of kidney disease
N with chronic kidney disease 2413 388a 326a 209a
N with acute kidney disease 2499 368a 275a 185a
N with glomerulonephritis 2666 375c 245c 177a
N with hereditary cystic kidney disease 706 109c 70c 49c
N with kidney or urinary tract malformations 2065 23 193b 152a
LBW, low birth weight; SGA, small for gestational age.
aP < 0.001.
bMaternal disease was defined as maternal diabetes mellitus, kidney disease, rheumatic disease, or essential hypertension diagnosed before pregnancy.
cP < 0.01 as compared with the group with neither individual nor sibling with LBW.
A Gjerde et al.: Familial Contributions to Low Birth Weight and CKD CLINICAL RESEARCHlogistic regression statistics. In adjusted analyses,
gender, pregestational maternal disease, maternal
marital status, and congenital malformations in the
newborn were included in the logistic regression sta-
tistics and aORs were obtained. In separate analyses
focusing on the associations in adulthood, only in-
dividuals born before 1990 were included.
In secondary analyses, we used Cox regression sta-
tistics to complement the logistic regression statistics.
Exposure and outcome variables were the same as in
the logistic regression analyses. Time until end point
was calculated as number of months from birth to first
occurrence of an exposure, and time until right
censoring was calculated as number of months from
birth to death or from birth until end of 2016. As we
did not have data on outcomes until 2008, analyses
were left truncated for the time period until 2008.
Graphs of cumulative risk (hazard) were prepared us-
ing the Nelson–Aalen estimate of risk groups.
A two-tailed probability value of less than 0.05 was
considered significant. Mean plus or minus SD is given
for continuous variables, and estimate (95% confidence
interval) is given for risk estimates. All analyses were
performed using STATA version 15.1 (Stata Corp.,
College Station, TX).
RESULTS
This study included a total of 1,849,411 individuals, of
whom 1,006,859 individuals had 1 sibling, 633,746 had
2 siblings, and 208,806 had 3 or more. Mean number of
siblings was 1.6 plus or minus 0.8, and mean number of
years of follow-up was 28.4 plus or minus 12.7 years.
Of the included individuals, 2413 were diagnosed with
CKD, 2499 with acute kidney disease, 2666 withKidney International Reports (2021) 6, 2151–2158glomerulonephritis, 706 with hereditary cystic kidney
disease, and 2065 individuals with kidney or urinary
tract malformations.
Characteristics of included individuals for 4 sub-
groups based on whether the individuals or at least one
of his or her siblings had LBW are found in Table 1. As
compared with individuals who neither had LBW
themselves or a sibling with LBW, adverse birth-
related risk markers were as expected more common
for individuals who themselves had LBW, but were
also more common for individuals who had a sibling
with LBW.
Risk of CKD
Compared with individuals who did not have siblings
with LBW, having at least 1 sibling with LBW was
associated with an OR of 1.38 (1.25–1.50) for develop-
ment of CKD. Similar associations were observed for
SGA and preterm birth with ORs of 1.36 (1.24–50) and
1.35 (1.25–1.46) respectively. As stated previously,
adverse birth-related risk markers were more common
in individuals who had a sibling with LBW, and this
could confound the analyses. In further analyses, we
therefore analyzed the combined effects.
Compared with individuals without LBW and with
no siblings with LBW, individuals without LBW but a
sibling with LBW had an OR of 1.31 (1.18–1.46), in-
dividuals with LBW but no siblings with LBW had an
OR of 1.80 (1.60–2.02), and individuals with LBW and a
sibling with LBW had an OR of 1.80 (1.56–2.08)
(Table 2 and Figure 1). After adjustments for sex,
maternal disease, and number of recorded siblings,
results were almost identical. The analyses were
repeated for SGA, preterm birth, and having at least 12153
Table 2. Risk of CKD according to whether the individual or at least 1 of his/her siblings had LBW, SGA, or preterm birth. Norway, 1967 to 2016
Subject Sibling N (total) n (CKD)
Unadjusted model Adjusted modela
OR P value OR P value
Not LBW Not LBW 1,480,658 2413 1.0 (ref) 1.0 (ref)
LBW 181,119 388 1.31 (1.18–1.46) <0.001 1.33 (1.19–1.49) <0.001
LBW Not LBW 111,061 326 1.80 (1.60–2.02) <0.001 1.74 (1.55–1.95) <0.001
LBW 71,391 209 1.80 (1.56–2.08) <0.001 1.77 (1.54–2.04) <0.001
Not SGA Not SGA 1,425,817 2337 1.0 (ref) 1.0 (ref)
SGA 160,734 323 1.23 (1.10–1.39) <0.001 1.25 (1.11–1.41) <0.001
SGA Not SGA 109,379 320 1.79 (1.59–2.00) <0.001 1.74 (1.55–1.95) <0.001
SGA 62,188 207 2.03 (1.76–2.34) <0.001 2.03 (1.76–2.34) <0.001
Not preterm birth Not preterm birth 1,665,238 2926 1.0 (ref) 1.0 (ref)
Preterm birth 102,736 219 1.21 (1.06–1.39) 0.006 1.23 (1.07–1.41) 0.003
Preterm birth Not preterm birth 60,597 161 1.51 (1.29–1.77) <0.001 1.44 (1.27–1.69) <0.001
Preterm birth 17,494 40 1.30 (0.95–1.78) 0.098 1.24 (0.91–1.70) 0.2
Not LBW 2.5 kg Not LBW 2.5 kg 1,684,907 2938 1.0 (ref) 1.0 (ref)
LBW 2.5 kg 108,507 232 1.23 (1.07–1.40) 0.003 1.24 (1.08–1.42) 0.002
LBW 2.5 kg Not LBW 2.5 kg 40,928 149 2.09 (1.77–2.46) <0.001 2.08 (1.80–2.45) <0.001
LBW 2.5 kg 11,723 27 1.32 (0.90–1.93) 0.151 1.30 (0.90–1.91) 0.166
Not LBW, SGA, or preterm birth Not LBW, SGA, or preterm birth 1,319,347 2088 1.0 (ref) 1.0 (ref)
LBW, SGA, or preterm birth 252,227 492 1.23 (1.17–1.36) <0.001 1.20 (1.08–1.33) 0.001
LBW, SGA, or preterm birth Not LBW, SGA, or preterm birth 154,815 407 1.66 (1.50–1.85) <0.001 1.50 (1.50–1.88) <0.001
LBW, SGA, or preterm birth 119,676 359 1.90 (1.70–2.12) <0.001 1.70 (1.50–1.90) <0.001
CKD, chronic kidney disease; LBW, low birth weight; OR, odds ratio; ref, reference; SGA, small for gestational age.
aAdjusted for gender, maternal disease (defined as maternal diabetes mellitus, kidney disease, rheumatic disease, or essential hypertension diagnosed before pregnancy), and number
of recorded siblings categorized as 1, 2, or greater than or equal to 3.
CLINICAL RESEARCH A Gjerde et al.: Familial Contributions to Low Birth Weight and CKDof the 3 risk markers. SGA analyses revealed almost
identical results, whereas preterm birth seemed to have
a less pronounced association (Table 2 and Figure 2).
Being born with LBW, SGA, or before 37 weeks of
gestation was associated with higher risks than having
a sibling with one of these risk markers, but the latter
was consistently associated with ORs of 1.2 to 1.3.
Unexpectedly, no considerable risk increase was
observed when both the individual himself and his
sibling had the risk factor. In a separate analysis in
which a cutoff for birth weight of 2.5 kg was used to
define LBW, we found that as compared withFigure 1. Cumulative risk of CKD according to whether the individual
or at least one of his or her siblings had LBW. Risk of CKD was
increased both for individuals who had LBW themselves and for
those who themselves did not have LBW but who had a sibling with
LBW. The graphs separate most strongly in adult age. CKD, chronic
kidney disease; LBW, low birth weight.
2154individuals without LBW and with no siblings with
LBW, individuals without LBW but a sibling with
LBW had an OR of 1.23 (1.07–1.40), those with LBW
but no siblings with LBW had an OR of 2.08 (1.77–
2.46), and those with LBW and a sibling with LBW had
an OR of 1.32 (0.90–1.93) (notably, only 27 individuals
developed CKD in this latter group). After adjustments,
almost identical results were found (Table 2). These
analyses were repeated separately for men and women.
The results revealed that having a sibling with LBW orFigure 2. Cumulative risk of CKD according to whether the individual
or at least one of his or her siblings was born SGA. Risk of CKD was
increased both for individuals who had SGA themselves and for
individuals who themselves did not have SGA but who had a sibling
with LBW. The graphs separate most strongly in adult age. CKD,
chronic kidney disease; LBW, low birth weight; SGA, small for
gestational age.
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Table 3. Risk of CKD according to number of risk markers in the individuals (LBW, SGA, or preterm birth) and siblings
Siblings No. of risk markers Total, N
Unadjusted model Adjusted modela
Cohort born before 1990
Adjusted modela
OR (95% CI) P value aOR (95% CI) P value Total, N aOR (95% CI) P value
No sibling with LBW, SGA, or preterm birth 0 1,257,320 1.0 (ref) 1.0 (ref) 628,773 1.0 (ref)
1 74,756 1.35 (1.15–1.60) <0.001 1.31 (1.14–1.54) <0.001 42,229 1.21 (1.02–1.45) 0.029
2 71,081 1.90 (1.63–2.20) <0.001 1.81 (1.56–2.10) <0.001 38,154 1.70 (1.45–2.00) <0.001
3 4176 2.59 (1.60–4.20) <0.001 2.41(1.50–4.00) 0.001 1765 3.00 (1.72–4.94) <0.001
At least 1 sibling with LBW, SGA, or preterm birth 0 237,385 1.24 (1.17–1.38) <0.001 1.26 (1.14–1.40) <0.001 129,396 1.18 (1.05–1.32) <0.003
1 41,761 1.83 (1.52–2.20) <0.001 1.81 (1.50–2.16) <0.001 24,427 1.60 (1.31–1.96) <0.001
2 67,277 1.92 (1.66–2.23) <0.001 1.90 (1.64–2.20) <0.001 38,228 1.82 (1.56–2.12) <0.001
3 5703 2.80 (1.90–4.14) <0.001 2.62 (1.76–3.90) <0.001 2600 2.91 (1.87–4.52) <0.001
aOR, adjusted odds ratio; CI, confidence interval; CKD, chronic kidney disease; LBW, low birth weight; No., number; OR, odds ratio; ref, reference; SGA, small for gestational age.
aAdjusted for gender, maternal disease (defined as maternal diabetes mellitus, kidney disease, rheumatic disease, or essential hypertension diagnosed before pregnancy), and number
of recorded siblings categorized as 1, 2, or greater than or equal to 3.
A Gjerde et al.: Familial Contributions to Low Birth Weight and CKD CLINICAL RESEARCHSGA tended to be associated with higher risks for men
than women (Supplementary Table S1).
We compared the unadjusted results in Table 2
during the first 40 years of life with those from the
previous study by Ruggajo et al.15 of risk of ESKD.
These analyses revealed much similar results, but there
was a trend toward higher risk estimates in this study
of CKD (Supplementary Table S2). The analyses from
Table 2 were also repeated using Cox regression sta-
tistics, revealing nearly identical results (results not
found). As hereditary or congenital kidney disease
could cause LBW or SGA, we performed a separate
analysis excluding all individuals who on at least 1
occasion had been diagnosed with hereditary cystic
disease or congenital kidney disease, revealing nearly
identical results.
In the analyses in Table 3, we analyzed whether OR
of CKD increased with higher number of birth-related
risk markers in the included individuals (LBW, SGA,
or preterm birth). Analyses were stratified based on
whether at least one of the siblings had at least one of
the risk markers. As can be found, individuals who had
a higher number of risk markers had higher risks. This
was evident in both individuals who had siblings
without risk markers and those who had siblings with
risk markers. Individuals who had a sibling with LBW,
SGA, or preterm birth, and who themselves had 3 risk
factors, had the highest risk with an aOR of 2.6 (1.8–
3.9). Individuals with 0 risk markers but who had a
sibling with LBW, SGA, or preterm birth had a sta-
tistically significantly increased risk with aOR of 1.3
(1.1–1.4). Similar findings were found for individuals
born before 1990 and thus revealed to be the same in
the adult population. Similar results were found using
Cox regression statistics (results not found).
Risk of Various Forms of Kidney Disease
In further analyses, we analyzed risk of various forms
of kidney disease based on whether the individual or at
least one of his/her siblings had LBW, SGA, or preterm
birth. These analyses were performed on much theKidney International Reports (2021) 6, 2151–2158same data set as in our previous study, and age dif-
ferences at first diagnosis and combinations of di-
agnoses were the same14; patients diagnosed with
kidney or urinary tract malformations were diagnosed
at a younger age and CKD was diagnosed in older pa-
tients. Importantly, patients could be included in
several disease groups. Analyses revealed stronger as-
sociations for CKD than for the other forms of kidney
disease (acute kidney disease, glomerulonephritis, he-
reditary cystic kidney disease, and kidney or urinary
tract malformations) (Table 4).DISCUSSION
This study confirms previous studies revealing LBW
and SGA to be associated with a 70% to 80% higher
risk of CKD in adult age. This study is to the best of our
knowledge the first to show that siblings of individuals
with LBW, SGA, or preterm birth also have a statisti-
cally significant 20% to 30% higher risk of CKD.
Interestingly, if the individual him/herself had LBW,
SGA, or preterm birth, the risk did not increase further
if a sibling also had one of these risk markers. Of note,
the higher risk in siblings was statistically significant
also for other forms of kidney disease, such as acute
kidney disease, glomerulonephritis, and hereditary
kidney disease. Most previous studies have investi-
gated risk of end-stage kidney disease, which is a rare
end point; our study reveals an increased risk for most
stages of CKD.
In the 1980s, Barker et al.1 revealed that birth
weight was inversely associated with risk of cardio-
vascular and other metabolic diseases in adult life. The
associations between size at birth and disease in
adulthood have been explained by alterations in fetal
nutrition and endocrine status caused by intrauterine
malnutrition, resulting in a permanent change in the
structure, physiology, and metabolism of affected in-
dividuals, predisposing them to disease in adulthood.16
Nevertheless, LBW may also be explained by the genes
of the fetus and maternal genes affecting the quality of2155




Chronic kidney disease Acute kidney disease Glomerulonephritis
Hereditary cystic kidney
disease
Kidney or urinary tract
malformations
Subject n aOR (95% CI)a n aOR (95% CI)a n aOR (95% CI)a n aOR (95% CI)a n aOR (95% CI)a
Not LBW Not LBW 2413 1.0 (ref) 2499 1.0 (ref) 2666 1.0 (ref) 706 1.0 (ref) 2065 1.0 (ref)
LBW 388 1.33 (1.19–1.48) 368 1.23 (1.10–1.36) 375 1.16 (1.04–1.30) 109 1.31 (1.06–1.60) 236 0.96 (0.83–1.10)
LBW Not LBW 326 1.75 (1.56–2.00) 275 1.45 (1.28–1.64) 245 1.21 (1.06–1.38) 70 1.20 (0.99–1.60) 193 1.10 (0.94–1.28)
LBW 209 1.78 (1.54–2.05) 185 1.54 (1.33–1.80) 177 1.37 (1.18–1.60) 49 1.40 (1.04–1.81) 152 1.43 (1.21–1.70)
Not SGA Not SGA 2337 1.0 (ref) 2390 1.0 (ref) 2568 1.0 (ref) 715 1.0 (ref) 2107 1.0 (ref)
SGA 323 1.25 (1.11–1.40) 302 1.13 (1.00–1.29) 337 1.16 (1.04–1.31) 79 1.02 (0.82–1.30) 221 0.96 (0.77–1.10)
SGA Not SGA 320 1.74 (1.55–1.96) 316 1.71 (1.52–1.92) 236 1.20 (1.04–1.36) 66 1.13 (0.88–1.46) 156 0.91 (0.78–1.08)
SGA 207 2.03 (1.76–2.34) 164 1.60 (1.37–1.88) 160 1.42 (1.21–1.67) 47 1.52 (1.13–2.04) 111 1.21 (1.00–1.47)
Not preterm Not preterm 2926 1.0 (ref) 2956 1.0 (ref) 3082 1.0 (ref) 823 1.0 (ref) 2352 1.0 (ref)
Preterm 219 1.23 (1.07–1.41) 210 1.18 (1.02–1.35) 218 1.15 (1.0–1.32) 47 0.92 (0.70–1.24) 154 1.07 (0.90–1.26)
Preterm Not preterm 161 1.44 (1.23–1.70) 124 1.12 (0.67–1.05) 126 1.11 (0.93–1.33) 43 1.22 (0.90–1.70) 119 1.20 (1.0–1.44)
Preterm 40 1.24 (0.91–1.70) 46 1.47 (1.10–1.97) 40 1.22 (0.90–1.70) 21 1.91 (1.22–3.0) 30 1.01 (0.70–1.45)
aOR, adjusted odds ratio; CI, confidence interval; LBW, low birth weight; ref, reference; SGA, small for gestational age.
a
Adjusted for gender, maternal disease (defined as maternal diabetes mellitus, kidney disease, rheumatic disease, or essential hypertension diagnosed before pregnancy), and number
of recorded siblings categorized as 1, 2, or greater than or equal to 3.
CLINICAL RESEARCH A Gjerde et al.: Familial Contributions to Low Birth Weight and CKDthe intrauterine environment.4 A study from the MBR
of Norway suggested that both maternal and fetal ge-
netic factors may influence the duration of pregnancy.5
At the same time, gestational age and birth weight may
also be explained by environmental factors that often
are shared among relatives, such as smoking, diet, and
socioeconomic status. A study by Lunde et al.4 inves-
tigated the genetic contributions to birth weight and
found that approximately 50% of the variation in birth
weight could be explained by genetic factors and that
9% to 15% of the variation could be explained by
shared environmental factors. As kidney disease also
has clear genetic contributions,7–11,17 it has therefore
been suggested that the same genetic factors could
explain both LBW and risk of kidney disease. This
study has revealed that individuals with LBW have a
significantly higher risk than those who have a sibling
with LBW, thus strengthening the argument that in-
trauterine programming itself is an important risk
marker for adult kidney disease.
As discussed previously, an alternate explanation
could be that much of the increased risk in individuals
with LBW is because of genetic factors and shared
environmental factors, and not because of intrauterine
nephron endowment. Twin studies can provide an
opportunity to test some of these hypotheses as twins
share their maternal and early family environment
factors and some or all of their genes.18,19 These have
however revealed different results, and whereas a
meta-analysis from 2004 concluded that there was an
important contribution from shared genetic and envi-
ronmental factors,18 others have revealed that the
actual birth weight itself and fetoplacental factors seem
to be more important.19,20 In our study, we revealed a
contribution from familial factors but cannot discern2156whether this is because of genetic or shared environ-
mental factors. It is however important to note that the
20% to 30% higher risk for individuals who had a
sibling with LBW or SGA is much smaller than the
70% to 80% increased risk that was found if the in-
dividual himself had LBW or SGA. In line with pre-
vious studies of heredity in kidney disease,9–11 the risk
seems to be increased for most types of kidney disease
and not specific to particular diseases, although some
diseases have clear mendelian inheritance. A study by
Hoy et al.21 revealed that APOL1 risk allele status was
strongly associated with age-related nephron loss in
African Americans. Other genetic factors may have
similar effects in other populations.
It has been discussed earlier whether LBW, SGA, or
preterm birth is the most important risk marker. This
study confirms previous findings from our group that
LBW and SGA seem to be equally important and that
preterm birth seems to be a weaker risk marker.14,22
This contrasts other studies which have revealed that
preterm birth is also an important risk marker.23,24
In this study, similar to our previous studies, we did
not observe significant sex differences in the associa-
tion between LBW and SGA and later kidney disease. It
was however interesting to find that having a sibling
with LBW was only statistically significantly associated
with CKD for men and not for women. The same trend
could be found also for SGA and preterm birth with
weaker effects in women than men.
The major strengths of our study are the opportu-
nity to use the national registries to include a large
number of participants with sibling data and pro-
spective registration of birth-related variables of high
quality. The long follow-up period of 50 years and the
fact that most kidney disease diagnoses are assessedKidney International Reports (2021) 6, 2151–2158
A Gjerde et al.: Familial Contributions to Low Birth Weight and CKD CLINICAL RESEARCHand treated in hospitals and thus included in this study
are also important. The study population is mostly
Caucasian, which is both a strength as the population is
quite homogenous and a weakness as our findings may
not have similar strength for other ethnic groups.
Another strength of our study is that the Norwegian
health care system is founded on the principles of
universal access and individuals with a low socioeco-
nomic status have the same access and right as the rest
of the population.
The main weakness is that we could not record end
points until 2008. Our data thus reflect prevalence of
CKD during the years 2008 to 2015. Given the wide age
range of 0 to 50 years, we believe that our data also
could reflect incidence of CKD. Based on these re-
flections, we decided to perform the main statistics as
logistic regression statistics, but also performed left-
truncated survival statistics to investigate the age-
associated risk of CKD. These 2 approaches revealed
mainly identical results. It is also possible that there
was under-reporting of CKD in our study, as only
diagnosed kidney disease that is relevant for the pa-
tient care is recorded, not all patients who fulfill the
criteria for CKD according to reduced estimated
glomerular filtration rate or albuminuria. The treating
physicians decide which ICD-10 diagnostic codes to
use, and although we believe that these mostly are
correct, diagnostic codes of kidney disease have to the
best of our knowledge not been validated in Norway.
Other limitations include lack of data on other impor-
tant risk factors, such as diabetes, hypertension,
smoking, dyslipidemia, and other exposures of kidney
disease. It would also be interesting to have data on
birth weight of individual’s mothers and fathers, but
these data were not available.
In conclusion, our findings strengthen the hypoth-
esis that intrauterine environment is important for risk
of kidney disease in adult life. There is however a
significant contribution from familial factors that could
be related to either genetic or environmental factor.
Future studies should attempt to identify which genes
or environmental factors could explain the association
between intrauterine growth restriction, nephron
number, and risk of kidney disease in adult life.DISCLOSURE
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